155 related articles for article (PubMed ID: 6305850)
1. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.
Moss DJ; Burrows SR; Castelino DJ; Kane RG; Pope JH; Rickinson AB; Alpers MP; Heywood PF
Int J Cancer; 1983 Jun; 31(6):727-32. PubMed ID: 6305850
[TBL] [Abstract][Full Text] [Related]
2. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.
Whittle HC; Brown J; Marsh K; Greenwood BM; Seidelin P; Tighe H; Wedderburn L
Nature; 1984 Nov 29-Dec 5; 312(5993):449-50. PubMed ID: 6095104
[TBL] [Abstract][Full Text] [Related]
3. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
4. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
[TBL] [Abstract][Full Text] [Related]
5. Malaria antibody levels in patients with Burkitt's lymphoma.
Feorino PM; Mathews HM
Am J Trop Med Hyg; 1974 Jul; 23(4):574-6. PubMed ID: 4367834
[No Abstract] [Full Text] [Related]
6. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
Rowe M; Rooney CM; Rickinson AB; Lenoir GM; Rupani H; Moss DJ; Stein H; Epstein MA
Int J Cancer; 1985 Apr; 35(4):435-41. PubMed ID: 2985508
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.
Snider CJ; Cole SR; Chelimo K; Sumba PO; Macdonald PD; John CC; Meshnick SR; Moormann AM
PLoS One; 2012; 7(3):e31753. PubMed ID: 22427806
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and malaria in relation to Burkitt's lymphoma in Papua New Guinea.
Moss D
P N G Med J; 1986 Mar; 29(1):41-3. PubMed ID: 3019040
[No Abstract] [Full Text] [Related]
9. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response.
Dias MHF; Guimarães LFF; Barcelos MG; Moreira EUM; do Nascimento MFA; de Souza TN; Pires CV; Monteiro TAF; Middeldorp JM; Soares IS; Fontes CJF; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010305. PubMed ID: 35921373
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin levels and malaria antibodies in Burkitt's lymphoma.
Nkrumah FK; Sulzer AJ; Maddison SE
Trans R Soc Trop Med Hyg; 1979; 73(1):91-5. PubMed ID: 375487
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the effect of acute P. falciparum malaria on Epstein-Barr virus: host balance in the setting of reduced malaria endemicity.
Jayasooriya S; Hislop A; Peng Y; Croom-Carter D; Jankey Y; Bell A; Dong T; Rowland-Jones S; Rickinson A; Walther M; Whittle H
PLoS One; 2012; 7(2):e31142. PubMed ID: 22347443
[TBL] [Abstract][Full Text] [Related]
12. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.
Moormann AM; Chelimo K; Sumba PO; Tisch DJ; Rochford R; Kazura JW
J Infect Dis; 2007 Mar; 195(6):799-808. PubMed ID: 17299709
[TBL] [Abstract][Full Text] [Related]
13. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children.
Whittle HC; Brown J; Marsh K; Blackman M; Jobe O; Shenton F
Clin Exp Immunol; 1990 May; 80(2):213-8. PubMed ID: 1972671
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
Carpenter LM; Newton R; Casabonne D; Ziegler J; Mbulaiteye S; Mbidde E; Wabinga H; Jaffe H; Beral V
Int J Cancer; 2008 Mar; 122(6):1319-23. PubMed ID: 18000823
[TBL] [Abstract][Full Text] [Related]
15. Association between HLA type and antibody response to malaria sporozoite and gametocyte epitopes is not evident in immune Papua New Guineans.
Graves PM; Bhatia K; Burkot TR; Prasad M; Wirtz RA; Beckers P
Clin Exp Immunol; 1989 Dec; 78(3):418-23. PubMed ID: 2482146
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea.
Beck HP; Felger I; Kabintik S; Tavul L; Genton B; Alexander N; Bhatia KK; al-Yaman F; Hii J; Alpers M
Am J Trop Med Hyg; 1994 Sep; 51(3):356-64. PubMed ID: 7943557
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control.
Gunapala DE; Facer CA; Davidson R; Weir WR
Parasitol Res; 1990; 76(6):531-5. PubMed ID: 2166284
[TBL] [Abstract][Full Text] [Related]
18. Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa.
Biggar RJ; Gardiner C; Lennette ET; Collins WE; Nkrumah FK; Henle W
Lancet; 1981 Jul; 2(8238):115-8. PubMed ID: 6113482
[TBL] [Abstract][Full Text] [Related]
19. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
20. Etiology of endemic Burkitt's lymphoma.
Olweny CL
IARC Sci Publ; 1984; (63):647-53. PubMed ID: 6100285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
